Prevalence and patterns of medication deintensification following severe hypoglycemia among older adults with diabetes

Study identification

• EU PAS number:
  EUPAS37902
• Study ID:
  39911
• Official title and acronym:
  Prevalence and patterns of medication deintensification following severe hypoglycemia among older adults with diabetes
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  This study will explore real-world deintensification practices of hypoglycemic medications following hypoglycemia-related ED visit or hospitalization in older adults with diabetes. Aim 1: We will examine the incidence of sulfonylurea and insulin deintensification following hypoglycemia-related ED visit or hospitalization and identify patient factors associated with deintensification. Aim 2: Explore patterns of diabetes regimen deprescribing and prescribing following hypoglycemia-related ED visit or hospitalization.
• Study status:
  Ongoing

Research institutions and networks

Institutions

University of North Carolina at Chapel Hill

Study timelines

Date when funding contract was signed

Planned:07/08/2020

Actual:07/08/2020

Study start date

Planned:07/08/2020

Actual:07/08/2020

Date of final study report

Planned:30/04/2020

Sources of funding

Other

More details on funding

NIH funding

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable